University of South Carolina

Scholar Commons
Faculty Publications

Psychology, Department of

1-28-2019

Knowledge and Awareness of Human Papillomavirus Among
College Students in South Carolina
Salima Kasymova
Sayward Harrison
University of South Carolina, HARRI764@mailbox.sc.edu

Caroline Pascal

Follow this and additional works at: https://scholarcommons.sc.edu/psyc_facpub
Part of the Psychology Commons

Publication Info
Published in Infectious Diseases: Research and Treatment, Volume 12, 2019.
© The Author(s) 2019 This article is distributed under the terms of the Creative Commons AttributionNonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits noncommercial use, reproduction and distribution of the work without further permission provided the
original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/enus/nam/open-access-at-sage).

This Article is brought to you by the Psychology, Department of at Scholar Commons. It has been accepted for
inclusion in Faculty Publications by an authorized administrator of Scholar Commons. For more information, please
contact digres@mailbox.sc.edu.

825077
research-article2019

IDR0010.1177/1178633718825077Infectious Diseases: Research and TreatmentKasymova et al

Knowledge and Awareness of Human Papillomavirus
Among College Students in South Carolina
Salima Kasymova, Sayward E Harrison

and Caroline Pascal

Infectious Diseases: Research and Treatment
Volume 12: 1–9
© The Author(s) 2019
Article reuse guidelines:
sagepub.com/journals-permissions
DOI: 10.1177/1178633718825077
https://doi.org/10.1177/1178633718825077

South Carolina SmartState Center for Healthcare Quality, Department of Health Promotion, Education,
and Behavior, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA.

ABSTRACT: Despite the existence of a safe and effective vaccine, human papillomavirus (HPV) remains prevalent in the United States, with late
adolescence and early adulthood being periods of increased risk. Thus, targeting college-aged individuals for HPV prevention and vaccination
promotion is critical—particularly in regions such as the Deep South where vaccination rates remain low. This study sought to examine awareness
and knowledge of HPV as well as experiences and attitudes regarding HPV vaccination among college students in the Deep South. Specifically,
we completed a cross-sectional survey of 256 undergraduate students from a large public university in South Carolina. Although a majority
of participants were aware of HPV, significant knowledge gaps existed, particularly regarding prevention, symptoms, and consequences of
HPV infection. Participants were also largely unaware of men’s susceptibility for negative HPV outcomes. Multivariate regression modeling was
used to identify predictors of HPV knowledge, with results indicating that participants who were female and white, as well as those who were
vaccinated, had higher levels of HPV knowledge. Findings highlight the need for comprehensive HPV education on college campuses and offer
insights to priority populations that may be appropriate focuses of efforts to increase HPV knowledge and vaccination rates.
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Introduction

and 17 have received at least one dose of the HPV vaccine, with
2 or 3 doses needed for full coverage depending on the selected
vaccine.6 HPV vaccination coverage among female adolescents
increased gradually following the vaccine’s approval for girls in
2006; in contrast, coverage among male adolescents has risen
rapidly since its approval for boys in 2011, resulting in a shrinking “gender-gap” in vaccination uptake.6 However, several
interesting racial and ethnic differences in HPV vaccination
coverage remain. Currently, African American and Hispanic
youth in the United States are significantly more likely to
receive the HPV vaccine than white, non-Hispanic youth, with
65.9% of African American adolescents and 69.8% of Hispanic
adolescents receiving at least one dose of the HPV vaccine,
compared to 54.7% of white, non-Hispanic youth.6
In addition, significant geographic disparities in HPV vaccination persist, with several states in the “Deep South” region
(eg, Mississippi, Alabama, South Carolina) falling significantly
below the national average and far below recommended
Healthy People 2020 goals of 80% coverage (see Figure 1).6,7
South Carolina is representative of these regional challenges,
with only 30.8% of females and 27.4% of males aged 13 to
17 years currently “up-to-date” with the HPV vaccination
series.6 This low uptake is particularly alarming given the estimated 30 000 new cases of anogenital cancer and 4000 deaths
from cervical cancer that are estimated to occur yearly in the
United States due to HPV.8 Regional differences in HPV vaccine uptake are likely to stem from complex and intersecting
factors including policy-related and socio-cultural factors, as

Around 79 million Americans are estimated to be infected with
genital human papillomavirus (HPV), the most common sexually transmitted infection in the world.1,2 Human papillomaviruses are a family of viruses that infect epithelial tissue; while
most types are low-risk and resolve spontaneously or become
undetectable, certain high-risk types—most notably HPV 16
and 18—are oncogenic, causing a wide range of cancers that
affect women (eg, cervical, vaginal, and vulvar cancers), men
(eg, penile cancer), and both sexes (eg, oropharyngeal and anal
cancers).2 HPV is prevalent among college-aged individuals
(eg, aged 18-22) due to increased rates of high-risk sexual
behaviors, including multiple sexual partners and engagement
in unprotected sex.3 Such behavioral risks yield high rates of
HPV, with data from 2007 to 2010 indicating an HPV prevalence of 59.8% among young women aged 20 to 24.4 Other
potential causes for increased HPV risk during this period have
been suggested and include a lack of engagement in preventive
care and limited HPV knowledge.5
Beginning in 2006, vaccination against the main types of
high-risk HPV has been available in the United States, with 3
vaccines (ie, Cervarix, Gardasil, Gardasil 9) currently approved
for use.2 Routine vaccination is recommended for male and
female adolescents at ages 11 to 12, though vaccination can
begin as early as age 9.2 Despite this recommendation, uptake
of the HPV vaccine has been slow and uneven in the United
States, with many youth remaining un- or under-vaccinated.2
Currently, only 60% of US adolescents between the ages of 13
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Figure 1. Estimated vaccination coverage with ⩾1 HPV vaccine among female (A) and male (B) adolescents aged 13 to 17 years—National Immunization
Survey-Teen, United States, 2016. HPV indicates human papillomavirus.
Reproduced from Walker et al.6

well as factors related to health care services and infrastructure.
In the United States, youth residing in rural areas (ie, nonMetropolitan Statistical Areas) are less likely to receive the
HPV vaccine than non-rural peers, possibly due to fewer pediatric primary care providers in these areas.6,9 These urban-rural
disparities are not present for Tdap coverage, suggesting that a
lack of access to vaccines is not a likely reason for low HPV
vaccination among rural adolescents.6 Regional and state variation in HPV vaccination may also be due to lower levels of
HPV knowledge and awareness among residents and unwillingness or discomfort of providers to initiate discussions about
HPV with families.5 Some Southern states such as Georgia
have had success in rapidly increasing adolescent HPV vaccination rates through a variety of initiatives, including statewide
health promotion campaigns, policy-related efforts, and the
development of vaccination partnerships with local health
departments and health care providers.10
Because HPV vaccination is recommended through age 21
for males and through age 26 for females and other priority
populations (eg, men who have sex with men, transgender individuals), college and university health systems have an important role to play in comprehensive, public health approaches to
reducing the burden of HPV. College health professionals may
work to raise awareness and knowledge of HPV, encourage the
adoption of healthy sexual practices, and provide vaccination to
willing students. College may be a particularly important window of opportunity for late HPV vaccination as it is a time
when individuals assume greater responsibility for their medical care and frequently begin to make medical decisions,
including receiving vaccination, without parental knowledge or
consent. Although much research on attitudes and beliefs of
HPV vaccination has focused on parents,11–14 an emerging
body of literature is beginning to explore how college students
make decisions about HPV vaccination. This literature suggests a positive association between students’ HPV knowledge,
perceptions of HPV vaccine acceptability, and actual uptake of
the vaccine.15,16

Given the need to target college-aged individuals in the
South for “catch-up” HPV vaccination, it is important to gain
a deeper understanding of factors that may increase their likelihood to be vaccinated and/or engage in other preventive
behaviors (eg, routine condom use). The Health Belief
Model17 provides a theoretical framework to investigate key
factors that may influence HPV-related behaviors, and suggests that an individual’s awareness and knowledge of HPV,
including perceived severity and risk, are likely to influence
HPV-related behaviors. Understanding college students’
HPV-related knowledge, attitudes, and perceived risk may
help to inform future interventions and policies aimed at
HPV-preventive behaviors, including “catch-up” vaccination
among college students. Thus, the purpose of this study was
to explore awareness and knowledge of HPV, as well as experiences and attitudes regarding HPV vaccination among college students in South Carolina, as well as to identify current
sources of HPV information. This information may serve as a
starting place to identify effective strategies and interventions
to increase HPV vaccination and thus reduce the prevalence
of high-risk strains of HPV among a key target population
(ie, college-aged individuals).

Method
Participants
A non-probability, purposive sample of college students from
South Carolina were recruited for this study from undergraduate courses in the College of Arts & Sciences and School of
Public Health at a large public university. The study protocol
was approved by the Institutional Review Board at the
University of South Carolina, which waived requirement for
written documentation of informed consent due to the study’s
minimal risk of harm. Interested students were provided with a
research information sheet that described study goals and
included potential benefits and risks of participation. This
sheet was reviewed with interested students, and in total, 256

Kasymova et al
participants consented to participate. All then individually
completed a paper-pencil survey in a classroom setting, with
data collection occurring between September and October of
2017. Students who participated were eligible to be entered
into a drawing for 1 of 6 US $25 incentives.

Measures
Demographic characteristics. Participants provided information
about demographics including age, gender, sexual orientation,
race, ethnicity, year in college, undergraduate major, and state
of home residence. Participants also reported whether they had
ever engaged in sexual contact with others.
HPV awareness, perceptions, and experiences. To assess awareness, participants were asked to report if they had “ever heard”
of HPV and the HPV vaccine, with response options including
“yes,” “no,” and “I don’t know.” Participants were asked if a
health care provider had ever recommended that they receive
the HPV vaccine and if they had received at least one dose of
the HPV vaccine (“yes,” “no,” “I don’t know”). Participants
rated their perceived risk for HPV infection using a 5-point
Likert scale, as well as the level of shame they would feel if they
found out they had HPV. Higher scores indicate greater perceived risk and more shame. Finally, participants were asked to
endorse any encountered sources of information of HPV (eg,
health care providers, friends, family, health classes, Internet).
HPV-Knowledge 18. For this study, we created an 18-item
HPV knowledge scale to assess participants’ accurate knowledge of HPV infection, HPV-related outcomes, HPV screening, and HPV prevention, with all items adapted from existing
published measures.16,18–21 Participants read a series of 18
statements on HPV and responded by endorsing “True,”
“False,” or “I don’t know.” Participants received one point for
each correct response; points were summed to create a total
knowledge score (ie, range of 0-18). The HPV-Knowledge 18
(HPV-K18) yielded strong internal consistency (α = .79).

Statistical analysis
We conducted statistical analysis using STATA. Initially, we
tabulated descriptive statistics for all variables. Chi-square tests
were calculated to examine differences in HPV awareness, vaccine awareness, vaccination status, and sources of HPV information by gender, race, and ethnicity. t Tests were used to
compare gender, race, and ethnicity differences in HPV knowledge; perceived risk for HPV; and HPV-associated shame. In
addition, we used t tests to compare differences in HPV knowledge based on reported sources of information. We then ran a
regression model with HPV knowledge as the outcome variable and predictor variables of age, gender (male, female), race
(non-white, white), ethnicity (Hispanic/Latino, not Hispanic/
Latino), history of sexual activity (no, yes), and HPV vaccination status (no/don’t know, yes).

3

Results

Demographic and behavioral characteristics of participants are
shown in Table 1. The majority of the sample was female
(80.9%), white (78.5%), and not of Hispanic or Latino ethnicity (88.7%). Participants ranged from 18 to 31 years of age
(M = 19.7 SD = 1.7). About half of participants (50.7%)
reported being from South Carolina, with 78.5% from the
Southern United States. Most participants (96.1%) identified
as heterosexual, with 84.8% reporting a history of sexual
activity.
The vast majority of the participants reported being aware of
HPV (95.3%) and the HPV vaccine (90.6%) prior to the day of
the survey. Ethnicity was not significantly associated with
awareness; however, some differences were observed by gender
and race. Female participants were more likely than males to
report HPV awareness (97% vs 88%, P = .005) and awareness of
the HPV vaccine (95% vs 76%, P < .001). In addition, white
participants were more likely than non-white participants (97%
vs 90%, P = .04) to report awareness of HPV. Self-reported vaccination rates fell well below Healthy People 2020 targets, with
64.1% of participants reporting having received at least one
dose of the HPV vaccine. A larger proportion (72.7%) indicated
that a physician or other health care provider had previously
recommended that they receive the vaccine. Those who were
vaccinated did not differ significantly by gender, race, and ethnicity when compared with those who were not vaccinated.
A summary of participant responses on HPV-K18 items are
presented in Table 2. Participants’ mean total knowledge score
was 8.9 (SD = 3.7), indicating moderate levels of overall HPV
knowledge (ie, potential range of 0-18). Significant differences
in HPV knowledge existed between genders and races. Female
participants displayed greater overall HPV knowledge (M = 9.2)
than male participants (M = 7.2, P = .02), and white participants
displayed higher levels of knowledge (M = 9.3) than non-white
participants (M = 7.7, P = .01).
Item analysis revealed patterns of knowledge gaps regarding
HPV. For instance, participants were largely incorrect in
responding to items about men and HPV. Only 7% of participants correctly responded to an item that asked whether
screening is commonly used to test men for HPV (ie, currently
there is no approved test for HPV in men), and only 36% knew
that HPV may cause penile cancer. Participants displayed confusion about the distinction between HPV and genital herpes,
with only 13% of participants aware that HPV does not cause
genital herpes. Participants underestimated the prevalence of
HPV, with just 15% correctly indicating that at some point
almost all sexually active women and men will contract HPV.
Although a majority of participants (53%) understood that
HPV can cause genital warts, a much smaller portion (9%)
were familiar with the fact that most HPV infections will clear
on their own. Moreover, more than half of the respondents
(51%) were unaware that there is no cure for HPV. On the
other hand, some aspects of HPV knowledge seemed well
understood by the majority of participants, including that
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Table 1. Demographic characteristics and HPV experiences of study
participants (N = 256).a
Variable

No. (%)

Mean (SD)

Gender
Female
Male

207 (80.9)

Black or African American

31 (12.1)

White

201 (78.5)

Other

2 (0.8)

Not reported

7 (2.7)

Mean (SD)

1 (0.4)

244 (95.3)
12 (4.7)

No/Do not know
Not reported

232 (90.6)
23 (9.0)
1 (0.4)

Has a health care provider
recommended the HPV vaccine to
you?
Yes
No/Do not know

186 (72.7)
70 (27.3)

Have you received at least one dose
of the HPV vaccine?

Ethnicity

Not reported

No. (%)

Ever heard of the HPV vaccine?
Yes

2 (0.8)
13 (5.1)

Other

No/Do not know
19.7 (1.7)

Asian

Not Hispanic or Latino

Not sure

Yes

49 (19.1)

Race

Hispanic or Latino

Variable

Ever heard of HPV?

Age

 American Indian or Alaskan
Native

Table 1. (Continued)

8 (3.1)
227 (88.7)
9 (3.5)
12 (4.7)

State of home residence
Northeast

31 (12.1)

Midwest

15 (5.9)

South

201 (78.5)

West

8 (3.1)

Other

1 (0.4)

Yes
No/Do not know

164 (64.1)
91 (35.5)

Perceived risk of HPV infection (on a
5-point scale)b

2 (1.2)

Perceived shame associated with
HPV infection (on a 5-point scale)b

4 (1.0)

Total HPV knowledge (out of 18 total
points)b

8.9 (3.7)

Abbreviation: HPV, human papillomavirus.
aMissing values are not shown in the table but are listed here by number missing:
age (4), perceived risk of HPV infection (2), total HPV knowledge score (6), and
received one dose of HPV vaccine (1).
bHigher scores indicate greater perceived risk for HPV, HPV-related shame, and
HPV knowledge.

Year in school
Freshman

72 (28.1)

Sophomore

62 (24.2)

Junior

62 (24.2)

Senior

58 (22.7)

Other

1 (0.4)

Not reported

1 (0.4)

Sexually active
No

39 (15.2)

Yes

217 (84.8)

Sexual orientation
Heterosexual (straight)

246 (96.1)

Gay or lesbian

5 (2.0)

Bisexual

4 (1.6)

HPV is sexually transmitted (85%), that HPV can lay dormant
in the body without symptoms (81%), and that having a greater
number of sexual partners increases a person’s chance of acquiring HPV (80%).
Individual items were also analyzed to assess for gender differences (see Table 2). When compared with female participants, males were less likely to know that an abnormal Pap
smear may indicate HPV for women (49% vs 72%, P < .01)
and were also less likely to know about HPV’s association with
cervical cancer (57% vs 82%, P < .01). Female participants were
more likely than males to be aware that HPV infections may be
asymptomatic (84% vs 67%, P = .01) and that it is possible for a
person to acquire more than one type of HPV (70% vs 51%,
P = .01). Females also were more knowledgeable that there is
currently no cure for HPV (52% vs 35%, P = .03) and that HPV
is a common virus (76% vs 59%, P = .02) as compared with their
male counterparts.
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Table 2. Number and percentage of participants correctly answering HPV-Knowledge 18 items and gender differences by item.a
HPV-K18 item (Correct response)

No. (%)

Pvalue

Female

Male

Total

1. HPV is a sexually transmitted infection. (T)

174 (84)

43 (88)

217 (85)

.52

2. There is a cure for HPV. (F)*

108 (52)

17 (35)

125 (49)

.03

3. Having one type of HPV means that you cannot acquire new types. (F)*

145 (70)

25 (51)

170 (66)

.01

16 (8)

1 (2)

17 (7)

.15

149 (72)

24 (49)

173 (68)

.00

6. Most genital HPV infections do not clear up on their own. (F)

19 (9)

5 (10)

24 (9)

.80

7. A person usually has symptoms when infected with HPV. (F)

112 (54)

20 (41)

132 (52)

.09

8. HPV is not a very common virus. (F)*

157 (76)

29 (59)

186 (73)

.02

9. HPV infection can cause genital warts. (T)

113 (55)

23 (47)

136 (53)

.34

27 (13)

5 (10)

32 (13)

.59

11. Certain types of HPV can lead to cervical cancer in women. (T)*

170 (82)

28 (57)

198 (77)

.00

12. HPV can lay dormant in the body for years without symptoms. (T)*

174 (84)

33 (67)

207 (81)

.01

13. A person’s chances of getting HPV increase with the number of sexual
partners they have. (T)

163 (79)

42 (86)

205 (80)

.30

14. Most people with HPV have visible signs or symptoms of the infection. (F)

107 (52)

25 (51)

132 (52)

.93

41 (20)

11 (22)

52 (20)

.68

115 (56)

30 (61)

145 (57)

.47

17. HPV can cause penile cancer. (T)

75 (37)

15 (31)

90 (36)

.49

18. Nearly all sexually active men and women will contract HPV at some point. (T)

28 (14)

9 (19)

37 (15)

.36

4. There is a screening that is commonly used to test males for HPV. (F)
5. An abnormal Pap smear may indicate that a woman has HPV. (T)*

10. HPV infection can cause genital herpes. (F)

15. Genital warts can cause cervical cancer. (F)
16. Condoms are not effective in preventing HPV. (F)

Abbreviation: HPV, human papillomavirus.
aMissing values are not shown in the table but are listed here by number missing: Item 6 (2), Item 12 (1), Item 13 (1), Item 17 (3), and Item 18 (2).
*Gender difference in correct response = P < .05.

Participants were also asked to indicate sources of knowledge of HPV, with the most reported sources being health care
provider (68%), school health education class (64%), and the
Internet (50%) (see Table 3). Female students were more likely
than males to report that they had learned about HPV from a
health care provider (73% vs 47%, P < .01), radio/TV (33% vs
12%, P < .01), and magazines/newspapers (19% vs 6%, P = .03).
We next examined whether a particular source of information
was associated with higher overall HPV knowledge scores.
Participants who reported learning about HPV from health
care providers (P = .03), school health education classes
(P < .01), and the Internet (P = .05) had higher levels of HPV
knowledge than those who did not endorse that particular
source of knowledge.
Finally, multivariate regression analysis was used to test
whether key demographic and behavioral variables significantly predicted higher HPV knowledge (see Table 4).
Specifically, the variables of gender, age, race, ethnicity, HPV
vaccination status, and history of sexual activity were included
in the regression model. Results of the regression indicated that

the predictors explained 8.2% of the variance (R2 = 0.08,
F(6, 237.4) = 3.5, P ⩽ .01). Three variables in the model were significant predictors of total HPV knowledge: gender, HPV vaccination status, and race. Being female significantly predicted
HPV knowledge (B = 1.20, SE = 0.59, P = .04), as did having
received the HPV vaccine (B = 1.25, SE = 0.48, P = .01). Finally,
being white also significantly predicted higher total HPV
knowledge (B = 1.21, SE = 0.60, P = .04). Age (B = 0.12,
SE = 0.14), ethnicity (B = 0.47, SE = 0.93), and sexual activity
(B = 0.84, SE = 0.63) were not significant (P > .05) in the model.

Discussion

This study aimed to explore knowledge and awareness of HPV
and HPV vaccination among male and female college students
in South Carolina. Results of our research are consistent with
recent studies that have found a substantial increase in HPV
awareness among college students over the past decade.21–24 In
this study, more than 9 out of every 10 participants were aware
of HPV and the HPV vaccine. Increasing awareness has been
the focus of multiple recent public health campaigns designed
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Table 3. Number and percentage of participants endorsing sources of
HPV information and gender differences.
Sources of HPV
information

Female
No. (%)

Male
No. (%)

Total
No. (%)

Pvalue

Health care
provider*

151 (73)

23 (47)

174 (68)

.00

School health
education class

131 (63)

32 (65)

163 (64)

.79

Internet

104 (50)

24 (49)

128 (50)

.87

Radio/TV*

69 (33)

6 (12)

75 (29)

.00

Family member

66 (32)

9 (18)

75 (29)

.06

Friend

49 (24)

12 (24)

61 (24)

.90

Magazine/
newspaper*

40 (19)

3 (6)

43 (17)

.03

Community health
program

16 (8)

1 (2)

17 (7)

.15

Other

6 (3)

2 (4)

8 (3)

.67

Centers for
Disease Control
and Prevention
(CDC) National
Sexually Tranmitted
Diseases (STD)
hotline

4 (2)

0 (0)

4 (2)

.33

Abbreviation: HPV, human papillomavirus.
*Gender difference = P < .05.

Table 4. Estimates from regression model predicting HPV knowledge
(R2 = 0.08, F(6, 237.4) = 3.5, P ⩽ .01).
Variable

b

SE

P

Intercept

2.65

3.06

Gender

1.20*

0.59

.04

Age

0.12

0.14

>.05

HPV vaccination status

1.25*

0.48

.01

Sexually active

0.84

0.63

>.05

Race

1.21*

0.60

.04

Ethnicity

0.47

0.93

>.05

Abbreviation: HPV, human papillomavirus.
*P ⩽ .05.

to promote the benefits of HPV vaccination to parents and
adolescents.25 Despite this high level of awareness, we found
many gaps in actual knowledge of HPV, similar to much prior
research.5,26,27 The majority of participants were uninformed
about the high prevalence of HPV in the general population, as
well as current options for screening and treatment.
Furthermore, many had limited knowledge about the causal
role of HPV in a variety of cancers and genital warts—

information that may be key in prompting vaccination. This
raises concerns that comprehensive information on HPV is not
reaching key youth populations. There is an urgent need to better educate college-aged individuals on HPV. Student health
and wellness programs should routinely evaluate the content
and impact of current HPV-related services to ensure that
comprehensive information on HPV, including the effectiveness of the HPV vaccine and opportunities for vaccination,
reach their intended audience.25
A second key finding was that the majority of college students in this study perceived their own risk for HPV to be low.
Although clinical HPV status was not evaluated in this study,
previous research with college populations has found a large
portion of women who believe themselves to be “not at risk” for
HPV actually test positive, with Ramirez et al28 finding a 35%
HPV prevalence rate among college women who perceived
themselves to not be at risk. Students also underestimated
overall prevalence, with only 15% of participants familiar with
the fact that nearly all US adults will acquire HPV at some
point in their lives. According to the Health Belief Model,17
low perceived risk for HPV is likely to decrease an individual’s
willingness to engage in vaccination or other preventive behaviors, such as routine condom use.15,29 Among the sample, there
was also widespread lack of awareness of the severity of HPV,
including its causal links with penile cancer and cervical cancer
(ie, particularly among male participants). Increasing college
students’ understanding of the likelihood of HPV acquisition
and the potential severity of the virus may promote important
preventive health behaviors. Making college students more
aware of how widespread HPV actually is may also serve to
reduce the high levels of shame associated with infection.
Consistent with previous research,21,24,26,30,31 we found that
young men were less aware of HPV and displayed poorer
knowledge than young women. Moreover, in comparison to
white students, non-white students were less likely to be aware
of HPV, had lower levels of HPV knowledge, and reported
lower perceived risk. These sex and racial differences are important, both for identifying priority populations for future college
health promotion campaigns and for exploring potential sociocultural and systemic factors that may underlie these disparities. Because many men do not develop visible symptoms of
HPV and there continues to be no approved male HPV screening tool, men often remain unaware of their positive HPV status—potentially contributing to lower levels of HPV awareness
and knowledge.32 In addition, numerous socio-cultural and
psychological variables also likely contribute to these observed
gender differences. Men have been dubbed “the forgotten fifty
percent”33 due to a history of omission from many aspects of
sexual and reproductive public health discourse. Societal beliefs
regarding gender-based power and gender norms (eg, norms
surrounding masculinity) contribute in complex ways to gendered behavioral health practices, and college-aged men have
identified multiple barriers to seeking health information and
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services, including social stigma and concerns about perceived
vulnerability.34 In addition to gender disparities, we also found
that non-white college students had lower levels of awareness
and knowledge than white individuals. This is concerning, particularly within the context of South Carolina, which has some
of the largest racial health disparities in the nation and where
African American women face significantly increased risk for
death from cervical cancer when compared with white
women.35 Reducing persistent disparities in HPV infection
among African American women36 and promoting equity in
the uptake of HPV vaccine is a public health priority, especially
in the Southern United States. To achieve these aims, more
research is needed to develop culturally specific frameworks of
behavioral decision-making regarding HPV, as well as culturally tailored HPV prevention interventions.37,38
In our sample, the majority of students indicated that they
would feel shame if they acquired HPV. This finding is concerning because shame associated with HPV may be a barrier
for cervical cancer screening.39 Shame may also hinder individuals from disclosing a positive HPV status to their partners
and/or families.40 Available literature suggests that the extent
to which the acquisition of HPV infection is perceived as
shameful is positively associated with awareness about the sexually transmitted nature of this virus and negatively associated
with knowledge of the high prevalence of HPV.39,41 Within
the current sample, the majority of college students knew about
the sexual transmission of HPV and had limited knowledge
about its high prevalence, which may have contributed to perceptions of HPV as “shameful.” Reducing the stigma associated with sexually transmitted infections and increasing open
communication about sexual health must be foundations of
health promotion campaigns designed to lower current rates of
HPV and increase acceptability of vaccination.
Finally, this study found that the college students received
information about HPV from a myriad of sources but overwhelmingly through health care providers, school health education classes, and the Internet. Health care providers who
work in college and university health centers thus have a critical role to play in promoting HPV vaccination for the “catchup” age rage (eg, through age 21 or 26), including assessing
vaccination status, initiating discussions about vaccination (ie,
for the un- or under-vaccinated), offering general HPV prevention messaging to all, and ensuring that routine screening
for cervical cancer is completed when indicated. In addition,
health outreach programs are needed campus-wide to increase
HPV awareness and improve knowledge. The rapid increase in
the consumption of online health information offers both
advantages (eg, ease of access, reduction of common barriers to
care such as stigma, transportation, and cost) and disadvantages
(eg, potential for misinformation) for college populations.
College and university health centers can take a lead in making
sure that students can access accurate and supportive health
information by ensuring that their websites contain reliable

7

information on HPV and the benefits of vaccination. A recent
study found video messaging to be an effective way to increase
HPV knowledge as well as vaccination intentions among college-aged individuals,42 and incorporating brief, educational
videos online or during patient visits may be a cost-effective
strategy. In addition, social networking sites (eg, Facebook,
Twitter, etc) may be effective mediums to deliver HPV vaccination messages though much more research is needed in this
domain.43

Limitations
Results of this research must be considered in the context of its
limitations. First, although the study’s findings on differences by
gender and race for HPV awareness and knowledge are important, they must be considered within the context of the sample.
The vast majority of individuals in this study were born in the
mid-to-late 1990s. Thus, many female participants were in the
first age cohort of girls eligible for HPV vaccination when the
vaccine was introduced for females in 2006. The recommendation for male vaccination not made until 2011, by then many
male participants were older than the recommended age range
of 10 to 11 years. Considering cohort effects on HPV, awareness
and knowledge is particularly important, given the major
changes in recommendations and uptake over the past decade.
Current data on HPV vaccination uptake in the United States
indicate that the male-female coverage gap is rapidly shrinking
and that racial and ethnic minorities are now vaccinated against
HPV at higher rates than non-minorities.6 Thus, these findings
are unlikely to generalize across age cohorts, and should, most
importantly, be used to inform current policy and programs that
aim to promote “catch-up” vaccination for college students in
South Carolina who may have missed opportunities for education and vaccination during their adolescence.
In addition, the study relied on self-reported data, and we
did not confirm participants’ HPV vaccination status or assess
the total number of doses received. To reduce the potential for
social desirability bias in responding, the survey was anonymous with no identifying data collected. Our sample presents
several limitations as well. The sample consisted of students
recruited from courses in public health, sociology, and other
disciplines. Because we did not employ a probability sampling
framework, our participants may not be representative of the
broader college population in South Carolina.

Conclusions

HPV remains a critical issue in the United States, and increasing
preventive health behaviors, most notably HPV vaccination, is a
public health priority. College and university health services can
play a key role in promoting sexual health and assisting in “catch
up” vaccination efforts for the un- and under-vaccinated.
However, low perceived risk for HPV, limited HPV knowledge,
and high levels of HPV-associated shame may be barriers to

Infectious Diseases: Research and Treatment 

8

efforts to prevent HPV infection and increase vaccination coverage among college populations. Results of this study confirm the
need to accelerate efforts to improve HPV knowledge and
increase vaccination among college-aged individuals, particularly
in the Deep South. Future studies are needed to identify culturally appropriate frameworks that can speed the reduction of
HPV disparities across both places and populations.
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